Literature DB >> 12379163

Proteinuria: an underappreciated risk factor in cardiovascular disease.

Julián Segura1, Carlos Campo, Luis M Ruilope.   

Abstract

Changes in renal function produced by hypertension appear to be associated with higher cardiovascular morbidity and mortality. Indices of altered renal function (eg, microalbuminuria, increased serum creatinine concentrations, decrease in estimated creatinine clearance, or overt proteinuria) are independent predictors of cardiovascular morbidity and mortality. The Framingham Heart Study documented the relevance of proteinuria for cardiovascular prognosis in the community. The International Nifedipine GITS study: Intervention as a goal in Hypertension Treatment (INSIGHT) study assessed the role of proteinuria as a very powerful risk factor. Several studies demonstrated that microalbuminuria is a predictor of cardiovascular disease. It has been shown that the presence of microalbuminuria in primary hypertension carries an elevated cardiovascular risk. Furthermore, recent data indicate that even minor derangements of renal function are associated with an increase in cardiovascular risk factors, and promote progression of atherosclerosis. All these parameters should routinely be evaluated in clinical practice, and in the future must be considered in any stratification of cardiovascular risk in hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379163     DOI: 10.1007/s11886-002-0106-5

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  39 in total

Review 1.  Is microalbuminuria a predictor of cardiovascular and renal disease in patients with essential hypertension?

Authors:  V M Campese; S Bianchi; R Bigazzi
Journal:  Curr Opin Nephrol Hypertens       Date:  2000-03       Impact factor: 2.894

2.  Hypertensive vascular disease; description and natural history.

Authors:  G A PERERA
Journal:  J Chronic Dis       Date:  1955-01

3.  Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

Authors:  J F Mann; H C Gerstein; J Pogue; J Bosch; S Yusuf
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

4.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

5.  Development of hypertension in renal disease.

Authors:  J Brod; J Bahlmann; M Cachovan; P Pretschner
Journal:  Clin Sci (Lond)       Date:  1983-02       Impact factor: 6.124

Review 6.  Pathophysiology of obesity hypertension.

Authors:  J E Hall
Journal:  Curr Hypertens Rep       Date:  2000-04       Impact factor: 5.369

7.  "Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis.

Authors:  R D Toto; H C Mitchell; R D Smith; H C Lee; D McIntire; W A Pettinger
Journal:  Kidney Int       Date:  1995-09       Impact factor: 10.612

8.  Kidneys and primary hypertension--initiators, stabilizers or/and victim-aggravators?

Authors:  B Folkow
Journal:  Blood Press       Date:  1994-07       Impact factor: 2.835

9.  Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group.

Authors:  N B Shulman; C E Ford; W D Hall; M D Blaufox; D Simon; H G Langford; K A Schneider
Journal:  Hypertension       Date:  1989-05       Impact factor: 10.190

Review 10.  Renal consequences of arterial hypertension.

Authors:  L M Ruilope; J M Alcázar; J L Rodicio
Journal:  J Hypertens Suppl       Date:  1992-12
View more
  3 in total

1.  Cardiac disease in children with primary glomerular disorders-role of focal segmental glomerulosclerosis.

Authors:  Olanrewaju Adedoyin; Rachel Frank; Suzanne Vento; Marcela Vergara; Bernard Gauthier; Howard Trachtman
Journal:  Pediatr Nephrol       Date:  2004-02-10       Impact factor: 3.714

2.  Genetic analysis of albuminuria in collaborative cross and multiple mouse intercross populations.

Authors:  Jill Thaisz; Shirng-Wern Tsaih; Minjie Feng; Vivek M Philip; Yunyu Zhang; Liane Yanas; Susan Sheehan; Lingfei Xu; Darla R Miller; Beverly Paigen; Elissa J Chesler; Gary A Churchill; Keith Dipetrillo
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-01

Review 3.  Proteinuria and its relation to cardiovascular disease.

Authors:  Gemma Currie; Christian Delles
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-12-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.